ONI BioPharma Inc has entered a Collaboration Agreement with a major international diagnostics company regarding ONI’s unique biomarkers for early, middle and late stage colorectal cancer. Terms of the agreement have yet to be disclosed.
Read MoreCepheid announces it has received clearance from the FDA to market its Xpert MRSA/SA Skin and Soft Tissue Infection test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) in skin and soft tissue infections.
Read MoreSensiGen LLC has announced a new program to make the Company’s AttoSense HPV assay available to head and neck cancer researchers worldwide after recent studies showed that the success or failure of various treatment options (chemotherapy, radiation, extensive surgery) are largely determined by the viral load of Human Papillomavirus (HPV) in tissue samples from patients.
Read MoreResearchers have demonstrated a new instrument that makes it possible to detect and quantify multiple different clinically important proteins in a single tumor sample using conventional staining. Currently, pathologists usually need a separate tissue slice for each protein they want to examine, making it impossible to see how molecules interact within individual cells.
Read MoreAdvanDx announces it has received FDA 510(k) clearance of the Yeast Traffic Light PNA FISH to identify Candida yeast species directly from positive blood cultures. The Yeast Traffic Light is the latest addition to AdvanDx’s easy-to-use, molecular-based PNA FISH diagnostics platform that provides rapid identification of bloodstream pathogens in hours instead of days.
Read More